Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001771498-26-000002

Chief Executive Officer gave up 21,714 shares (to pay taxes)

  • Chief Executive Officer acquired 47,033 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shea Jacqueline Elizabeth Chief Executive Officer 2026-02-26 Option exercise +18,632 78,317 D
Shea Jacqueline Elizabeth Chief Executive Officer 2026-02-26 Shares withheld for taxes −8,057 $1.79 $14,422 70,260 D
Shea Jacqueline Elizabeth Chief Executive Officer 2026-02-26 Option exercise +28,401 98,661 D
Shea Jacqueline Elizabeth Chief Executive Officer 2026-02-26 Shares withheld for taxes −13,657 $1.79 $24,446 85,004 D
Derivatives
Shea Jacqueline Elizabeth Chief Executive Officer 2026-02-26 Option exercise · Restricted Stock Unit −18,632 18,631 D
Shea Jacqueline Elizabeth Chief Executive Officer 2026-02-26 Option exercise · Restricted Stock Unit −28,401 56,800 D
Loading xslF345X05/wk-form4_1772228868.xml…